Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation and Depletion (2019 - 2025)

Biodesix's Depreciation and Depletion history spans 7 years, with the latest figure at -$2.3 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 519.93% year-over-year to -$2.3 million; the TTM value through Dec 2025 reached $382000.0, down 88.6%, while the annual FY2025 figure was $482000.0, 85.62% down from the prior year.
  • Depreciation and Depletion reached -$2.3 million in Q4 2025 per BDSX's latest filing, down from $900000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.0 million in Q3 2024 to a low of -$2.3 million in Q4 2025.
  • Average Depreciation and Depletion over 5 years is $291200.0, with a median of $350000.0 recorded in 2021.
  • Peak YoY movement for Depreciation and Depletion: soared 3780.0% in 2024, then tumbled 519.93% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at -$186000.0 in 2021, then crashed by 227.42% to -$609000.0 in 2022, then surged by 97.54% to -$15000.0 in 2023, then skyrocketed by 3780.0% to $552000.0 in 2024, then crashed by 519.93% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Depreciation and Depletion are -$2.3 million (Q4 2025), $900000.0 (Q3 2025), and $900000.0 (Q2 2025).